Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Optimizing PPD Diagnosis and Treatment: The Role of Neuroactive Steroids and Multidisciplinary Care
Irritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
Irritable Bowel Syndrome: Clarifying the Vagaries and Improving Patient Care in Women
Current and Emerging Treatments for PTSD in Women: An In-Depth Overview
Current and Emerging Treatments for PTSD in Women: An In-Depth Overview
Redefining Treatment at First Relapse in RRMM: Exploring BCMA-Targeted Therapies
Redefining Treatment at First Relapse in RRMM: Exploring BCMA-Targeted Therapies
Treating At-Risk MASH: What Are You Waiting For?
Treating At-Risk MASH: What Are You Waiting For?
January 11, 2025
12:00 PM - 01:00 PM MST
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Love Story: Lipid Education for Women’s Heart Health
Love Story: Lipid Education for Women’s Heart Health
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care
Guidelines-recommended first-line treatment with immunotherapy-based regimens in PD-L1- positive metastatic NSCLC
Guidelines-recommended first-line treatment with immunotherapy-based regimens in PD-L1- positive metastatic NSCLC
Acoramidis reduces all-cause mortality in ATTR-CM
Acoramidis reduces all-cause mortality in ATTR-CM
